With seven additional Phase 3 readouts expected in 2026, retatrutide is emerging as a potential next-generation standard of care one that could fundamentally reshape the metabolic medicine landscape
Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agers H, Veldhuis J, et al
The pharmaceutical role of glycine Every injectable peptide faces a stability challenge
Schedule a consultation today to explore advanced therapies, supplements, and lifestyle strategies that protect your heart and optimize your health long-term
Finerenone in patients with chronic kidney disease and type 2 diabetes by sodiumglucose cotransporter 2 inhibitor treatment: the fidelity analysis
Get scientifically formulated nutritional support with four daily supplements in one convenient vitamin pack for people on GLP-1 medications or weight loss diets.